Respiri Limited announced that it has formed a Medical Advisory Board (MAB) with leading US Key Opinion Leaders (KOL) who will help forge the Company's respiratory clinical and product development strategies and guidance on further advancing wheezo® Remote Patient Monitoring (RPM) program as part of standard patient respiratory care. The founding MAB members comprise a wealth of experience and knowledge and a diverse skill set spanning clinical pulmonology, scientific & clinical expertise and commercial medical device development and commercialisation. William S. Krimsky, FCCP, DAABIP will serve as the MAB's first Chair and is a highly respected expert in interventional pulmonology and in the use of electromagnetic navigation bronchoscopy for the diagnosis and treatment of lung disease.

He has developed innovative techniques to treat diseases of the chest, and he travels nationally and internationally to teach these techniques. He also is medical director of clinical research at Pulmonary and Critical Care Associates of Baltimore. Dr. Krimsky specializes in robotic surgery and innovative treatments for lung cancer.

The newly appointed Medical Advisory Board members are: Professor Gerard J. Criner, MD, FACP, FACCP Chair and Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University. Dr. Gerard Criner received his medical degree from Temple University School of Medicine his clinical specialties include advanced lung diseases, airway disorders, COPD, interstitial lung disease, lung volume reduction, and lung transplantation. In 2015 he became the founding chair of the Department of Thoracic Medicine and Surgery.

Dr. Criner has extensive experience in conducting, designing, and leading multicentre trials for the past 25 years. He has been involved in multiple NIH steering committees, ad hoc technical panels, and work groups over the past 20 years. He has also developed several multicentred trials with industry that includes the use of lung coils (PneumRX), tissue glue (AERIS) and endobronchial valves to reduce hyperinflation in emphysema (LIBERATE, Pulmonx).

Dr. Criner has been recognized as part of the Best Doctors in America®, Pulmonary Medicine; Critical Care Medicine in 2015-2016, 2017-2018, 2019-2020. Ass. Professor Stephen Selinger, MD, is a graduate of the Johns Hopkins University School of Medicine.

He is an assistant professor at Georgetown University Medical Center, as well as a clinical instructor at Johns Hopkins University. Dr. Selinger is the Chief Medical Officer for Luminis Health Anne Arundel Medical Center. Dr. Selinger serves as the physician executive for Luminis Health Anne Arundel Medical Center, Luminis Health J. Kent McNew Family Medical Center, and Luminis Health Pathways.

Established in 1902 and located in Annapolis, Maryland, Luminis employees >6,500 staff, has 3 hospitals with 611 licensed beds and over 80 care sites accommodating in excess of 156,000 emergency visits per annum and almost 36,000 inpatient admissions, generating USD 1.1 billion pa in operating revenue. Prior to joining LHAAMC, Dr. Selinger served as the Chairman of the Department of Medicine, Director of the Critical Care and Medical Service Line, and Chairman of the Department of Medicine. At LHAAMC, he plays a critical role in medical staff governance, quality, safety, education, leader development, physician engagement, financial performance, and medical director partnerships.

Dr. Jonathan Hovda, M.D., M.B. A graduated from Medical School at the University of Minnesota, where he simultaneously also received a Master of Business Administration degree from the Carlson School of Management. He completed his residency in Internal Medicine at Abbott North-western Hospital in Minneapolis and fellowships in Pulmonary/Critical Care Medicine and Interventional Pulmonology at Wake Forest University in Winston-Salem, NC. He brings with him a perspective founded on a unique blend of clinical, medical and business backgrounds.

Dr. Hovda has special interests in lung cancer and advanced bronchoscopy, including robotic bronchoscopy and endobronchial ultrasound. He is board-certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine. He practices both inpatient and outpatient Pulmonary Medicine, and sees patients at Fridley, Edina, Minneapolis and Plymouth offices.